ARFGAP3

ARFGAP3 is a coatomer-dependent GTPase-activating protein for Arf1 that controls vesicle coat dynamics in the early secretory and endosomal pathways (PMID:19015319, PMID:11172815). Rather than binding membranes directly, it is recruited to COPI vesicles through interactions with coatomer, and in the presence of coatomer its GAP activity toward Arf1 equals or exceeds that of ArfGAP1, establishing a coat-coupled mechanism for triggering Arf1 GTP hydrolysis (PMID:19015319). Its catalytic activity is tuned by membrane lipids, being stimulated by phosphatidylinositol 4,5-bisphosphate and antagonized by phosphatidylcholine, and its overexpression blocks constitutive secretion, placing it in the early secretory pathway (PMID:11172815). Together with ArfGAP2, ARFGAP3 follows coatomer dynamics during vesicle budding and is required for proper assembly of the COPI coat lattice and for Golgi stacking and cisternal integrity (PMID:20858901). Beyond the Golgi, ARFGAP3 acts at the trans-Golgi network and early endosomes, where its GAP activity drives retrograde CIMPR transport, Cathepsin D maturation, and EGFR exit from endosomes, and it associates with GGA clathrin adaptors to support their membrane association (PMID:24076238). Additional roles have been documented in specialized contexts: at photoreceptor synaptic ribbons it binds the RIBEYE B-domain in an NAD(H)-dependent manner, with RIBEYE competing against Arf1 for ARFGAP3 and its overexpression suppressing endocytosis (PMID:24719103); and in skeletal muscle it co-localizes with COPI components and GLUT4 to support GLUT4 vesicle trafficking and glucose uptake (PMID:36476390).

1. 2001 High

   Established that ARFGAP3 is an enzymatically active Arf1 GAP whose activity is lipid-regulated and that it functions in the early secretory pathway, defining its core biochemical identity.

   Evidence In vitro GAP assay with phospholipid titration, subcellular localization, and a secretion reporter assay

   PMID:11172815

   Open questions at the time

   • Did not identify the coat machinery coupling ARFGAP3 to membranes
   • Physiological lipid context of PIP2/PC regulation not resolved in vivo
2. 2008 High

   Resolved how ARFGAP3 engages membranes by showing it does not bind lipids directly but is recruited via coatomer, which simultaneously activates its GAP activity — defining a coat-coupled catalytic mechanism distinct from ArfGAP1.

   Evidence In vitro GAP activity, membrane binding, and coatomer recruitment assays

   PMID:19015319

   Open questions at the time

   • Structural basis of the coatomer-ArfGAP3 interaction not defined
   • Functional division of labor between ArfGAP2 and ArfGAP3 unresolved
3. 2010 High

   Demonstrated that ARFGAP3 (with ArfGAP2) is a structural component of the COPI coat required for lattice assembly and Golgi integrity, elevating it from an activity-terminating enzyme to a coat-building factor.

   Evidence siRNA double knockdown, live-cell coatomer co-dynamics imaging, and electron microscopy of Golgi morphology

   PMID:20858901

   Open questions at the time

   • Mechanism by which GAP activity contributes to coat stability vs. uncoating not separated
   • Redundancy with ArfGAP2 prevents isolating ARFGAP3-specific structural role
4. 2013 High

   Extended ARFGAP3 function beyond the Golgi to the TGN and early endosomes, showing its GAP activity drives retrograde cargo transport and that it partners with GGA adaptors, broadening its trafficking footprint.

   Evidence Systematic siRNA specificity screen, GAP-dead rescue, immunofluorescence, Co-IP with GGAs, and cargo maturation/degradation assays

   PMID:24076238

   Open questions at the time

   • Whether the same coatomer-dependent mechanism operates at endosomes is unknown
   • Direct vs. indirect nature of the GGA association not fully resolved
5. 2014 High

   Identified a specialized synaptic-ribbon role in which ARFGAP3 binds RIBEYE in an NAD(H)-dependent manner and competes with Arf1, linking ARFGAP3 regulation to metabolic redox state and presynaptic endocytosis.

   Evidence Multiple Co-IP/pull-down assays, NAD(H) titration, Arf1-vs-RIBEYE competition, and FM1-43 endocytosis assay in photoreceptors

   PMID:24719103

   Open questions at the time

   • Physiological consequence of RIBEYE-mediated Arf1 protection in vivo not established
   • Generalizability beyond photoreceptor ribbons unknown
6. 2011 Medium

   Linked ARFGAP3 to cell proliferation and migration through a paxillin interaction and androgen receptor transactivation in prostate cancer cells, suggesting a role outside canonical trafficking.

   Evidence Overexpression and siRNA knockdown, Co-IP, AR luciferase reporter, and proliferation/migration assays

   PMID:21647875

   Open questions at the time

   • Mechanistic connection between GAP activity and AR transactivation not defined
   • Single-lab observation without reciprocal validation of the paxillin interaction
7. 2022 Medium

   Connected ARFGAP3-dependent vesicle transport to GLUT4 storage vesicle trafficking and glucose uptake in muscle cells, implicating it in metabolic cargo delivery.

   Evidence Immunofluorescence co-localization with COPI subunits and GLUT4, siRNA knockdown, glucose uptake, proliferation/apoptosis, and differentiation assays

   PMID:36476390

   Open questions at the time

   • Whether ARFGAP3 acts directly on GSV trafficking or upstream in the secretory pathway unresolved
   • Single-lab, single cell-model evidence
8. 2025 Medium

   Placed ARFGAP3 in an autophagy/IRS1-AKT-mTOR axis via Rab5a, proposing a protective role for mitochondrial and muscle function during ageing.

   Evidence Knockdown/overexpression cell lines, Rab5a genetic intervention, mRFP-GFP-LC3 flux, and an in vivo ageing model with autophagy inhibitor rescue

   PMID:39961359

   Open questions at the time

   • Biochemistry of the ARFGAP3-Rab5a interaction not resolved
   • Relationship between this signalling role and ARFGAP3's canonical GAP/coat function unclear

• How ARFGAP3's single coatomer-dependent Arf1 GAP activity is mechanistically partitioned across its diverse reported roles — COPI coat assembly, endosomal retrograde transport, synaptic-ribbon endocytosis, and muscle metabolic signalling — remains unresolved.
• No structural model of ARFGAP3 in any coat/complex
• Catalytic vs. structural contributions not separated across contexts
• In vivo loss-of-function consequences in mammals not characterized